Midatech Pharma Plc Insider ownership
What is the Insider ownership of Midatech Pharma Plc?
The Insider ownership of Midatech Pharma Plc is 11.91%
What is the definition of Insider ownership?
Insider Ownership is calculated as the total number of shares owned by insiders (shareholders who own more than 5% of the corporation or an officer or director of the company) divided by the total Shares Outstanding.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider ownership of companies in the Health Care sector on LSE compared to Midatech Pharma Plc
What does Midatech Pharma Plc do?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Companies with insider ownership similar to Midatech Pharma Plc
- Timberland has Insider ownership of 11.89%
- Precigen Inc has Insider ownership of 11.89%
- Idox Plc has Insider ownership of 11.90%
- Hanhua Co has Insider ownership of 11.90%
- Mexican Gold Mining has Insider ownership of 11.90%
- Smith Micro Software has Insider ownership of 11.91%
- Midatech Pharma Plc has Insider ownership of 11.91%
- Maitri Health Technologies has Insider ownership of 11.91%
- Radius Gold has Insider ownership of 11.93%
- Lazydays Inc has Insider ownership of 11.93%
- Salt Lake Potash has Insider ownership of 11.93%
- Golden Lake Exploration Inc has Insider ownership of 11.94%
- Studio City International has Insider ownership of 11.96%